1 What is this medicine
and what is it used for?
Methotrexate (MTX) is a folic acid antagonist that
competitively inhibits dihydrofolate reductase (DHFR), depleting active folate
cofactors essential for DNA synthesis, nucleotide production, and cell
proliferation. At low weekly doses (used for rheumatological and dermatological
conditions), its anti-inflammatory and immunomodulatory effects predominate,
likely through inhibition of the purine synthesis pathway and increased
adenosine signalling.
The 25 mg/0.5 mL pre-filled syringe formulation is for
subcutaneous (SC) injection — used primarily for:
• Rheumatoid arthritis (RA) — the
gold-standard DMARD; used as first-line monotherapy or in combination with
biologic agents.
• Psoriasis and psoriatic arthritis —
moderate-to-severe disease.
• Other inflammatory conditions:
Crohn's disease, adult-onset Still's disease, vasculitis, uveitis.
Note: High-dose intravenous or intrathecal methotrexate for
oncology is a separate formulation. The 25 mg SC pre-filled syringe is
specifically for DMARD use.
2 How to take this
medicine
The dose is given ONCE WEEKLY by SC injection — always on the
same day of the week. NEVER take daily — daily methotrexate is a
life-threatening medication error. Administer SC into the abdomen or thigh.
Rotate injection sites. Take folic acid 5 mg once weekly (on a different day
from methotrexate) to reduce side effects.
|
WEEKLY DOSING ONLY — CRITICAL SAFETY WARNING: Methotrexate for inflammatory conditions (RA,
psoriasis) is taken ONCE A WEEK — NOT every day. Daily administration of weekly methotrexate is
one of the most common fatal medication errors. Always verify the dosing
frequency. The prescription and dispensing label must
prominently state: 'ONCE WEEKLY ONLY'. If in doubt: NEVER give more than one dose in
any 7-day period. |
3 Possible side effects
|
Frequency |
Side Effect |
What to Do |
|
Very Common (>10%) |
Nausea / vomiting
(post-injection) |
Folic acid
supplementation reduces this significantly. Schedule injection on a day off. |
|
Very Common (>10%) |
Fatigue ('methotrexate
hangover' day after injection) |
Plan injection day to
minimise impact on work/activities. |
|
Very Common (>10%) |
Elevated liver enzymes |
Regular LFT monitoring
mandatory. Avoid alcohol. |
|
Common (1–10%) |
Mucositis / mouth
ulcers |
Folic acid helps
prevent; use soft toothbrush; avoid irritants. |
|
Common (1–10%) |
Bone marrow
suppression (neutropenia, anaemia, thrombocytopenia) |
Regular FBC
monitoring. Febrile neutropenia is an emergency. |
|
Common (1–10%) |
Alopecia (hair
thinning) |
Usually mild at DMARD
doses. |
|
Uncommon |
Methotrexate-induced
pneumonitis |
Seek urgent review for
new dry cough or breathlessness. |
|
Rare |
Hepatic fibrosis /
cirrhosis (cumulative dose-related) |
Regular LFT
monitoring; liver biopsy guidelines apply at high cumulative doses. |
|
Seek help urgently |
Fever + neutropenia,
severe breathlessness, severe mouth ulcers |
Emergency — possible
serious toxicity or bone marrow suppression. |
4 Contraindications
Methotrexate is contraindicated in: pregnancy (highly
teratogenic — strict contraception during treatment and for 3 months after in
women, 6 months after in men); breastfeeding; severe hepatic impairment; severe
renal impairment (eGFR < 20); active infections; significant
immunodeficiency; blood dyscrasias; excessive alcohol consumption.
5 Drug interactions
• NSAIDs (ibuprofen, naproxen,
diclofenac): reduce renal methotrexate clearance — increased toxicity risk;
avoid high-dose NSAIDs or monitor very closely.
• Trimethoprim / co-trimoxazole:
additive antifolate effect — significant myelosuppression risk; avoid.
• Proton pump inhibitors (omeprazole,
pantoprazole): may increase MTX levels — monitor.
• Ciclosporin: additive nephrotoxicity;
complex pharmacokinetic interaction.
• Alcohol: additive hepatotoxicity —
AVOID completely.
• Live vaccines: contraindicated.
6 Storage
Store at 2–8°C (refrigerate). Protect from light. Do not
freeze. Single use — discard any unused portion. Cytotoxic — handle with
gloves; dispose via pharmaceutical waste.
7 Prescription
requirement
|
PRESCRIPTION ONLY MEDICINE (POM) —
Rheumatologist, dermatologist, or specialist physician prescription. Monitoring (BEFORE starting): FBC, LFTs, renal
function (eGFR), CXR, hepatitis B/C serology, HIV. During treatment: FBC and
LFTs monthly for first 3 months, then every 3 months. Patient must carry
'Methotrexate Alert Card'. |
8 Guidance for patients
& caregivers
The single most important thing to remember about
methotrexate is: ONE injection ONCE A WEEK — never more. Taking it more
frequently than once a week is extremely dangerous and has caused deaths.
Take folic acid 5 mg on a different day each week (e.g.
methotrexate on Monday, folic acid on Thursday) — it significantly reduces
nausea, mouth sores, and hair loss without reducing methotrexate's therapeutic
effect.
Avoid alcohol completely — even small amounts of alcohol
combined with regular methotrexate significantly increase liver scarring risk.
Regular blood tests are essential and protect you from serious toxicity.
Report immediately to your rheumatology nurse: new dry cough
or breathlessness (possible lung inflammation), fever with chills, mouth ulcers
that are unusually severe or painful, or unusually pale or bruising.
9 Pharmacist &
prescriber notes
SC methotrexate has ~30% higher bioavailability than oral at
equivalent doses, with better GI tolerability — preferred at doses > 15
mg/week. The pre-filled syringe (25 mg/0.5 mL) is single-dose. NHSE/BSR shared
care protocols for RA require specific monitoring and communication. Folic acid
5 mg once weekly (or daily 1 mg except on MTX day) should always be
co-prescribed.
The MHRA patient safety alert mandates: all prescriptions
must state dose in mg AND state 'Once weekly'; dispensing labels must repeat
'Take once weekly on [day]'; patients must carry a methotrexate monitoring
booklet.
Drug interactions: trimethoprim must never be used in MTX
patients — switch to nitrofurantoin or cefalexin for UTI. NSAIDs: if essential,
monitor FBC and renal function closely.
10 Frequently asked
questions
Can I drink alcohol at all?
No — even small amounts of alcohol increase the risk of liver
scarring (fibrosis) when you are on regular methotrexate. This is one of the
firm lifestyle restrictions that is medically important, not just a general
caution.
Why do I feel tired and unwell the day after my injection?
This is the well-known 'methotrexate hangover' — systemic
effects in the 24–48 hours after injection. Taking your injection in the
evening can help you 'sleep through' the worst of it. Folic acid and good
hydration help. Some patients find the SC route causes fewer systemic effects
than oral.
What are the signs I need to go to hospital straight away?
Fever above 38°C (possible serious infection due to low white
cells); new dry cough or breathlessness (possible lung inflammation —
methotrexate pneumonitis); very severe mouth ulcers; or unusual
bruising/bleeding (low platelets).
How long will I be on methotrexate?
For RA and psoriasis, methotrexate is often taken long-term —
years or even indefinitely — as it continues to suppress disease activity. The
dose may be adjusted over time. Regular monitoring continues throughout.
Can I have vaccinations on methotrexate?
Inactivated vaccines (flu, pneumococcal, COVID-19 booster)
are safe and strongly recommended. Live vaccines (yellow fever, MMR) should be
avoided. Discuss your vaccination schedule with your rheumatologist.